Symptom control issues and supportive care of patients with head and neck cancers

Clinical Advances in Hematology and Oncology

Volumn 5, Issue 10, 2007, Pages 807-822

  Murphy, Barbara A ^a,b   Gilbert, Jill ^a   Cmelak, Anthony ^a   Ridner, Sheila H ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dermatitis; Head and neck cancer; Lymphedema; Mucositis; Supportive care; Xerostomia

Indexed keywords

ALOE VERA EXTRACT; ALUMINUM ACETATE SOLUTION; AMIFOSTINE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; APPETITE STIMULANT; BENZYDAMINE; CALAMINE; CALCIUM; CAPHOSOL; CEVIMELINE; DUODERM; ELECTROLYTE; FLUORIDE; HYDROCORTISONE; HYDROLASE; LANOLIN; LANOLIN ALCOHOL; MORPHINE; OPSITE; PENTOXIFYLLINE; PHOSPHATE; PILOCARPINE; PLACEBO; POLYURETHAN; TANNIN; UNINDEXED DRUG; XIPAMIDE; ZINC;

CANCER CONTROL; CLINICAL ASSESSMENT; CLINICAL TRIAL; DENTAL CARE; DYSPHAGIA; HEAD AND NECK CANCER; HUMAN; HYPOTENSION; LYMPHEDEMA; METABOLIC DISORDER; MORBIDITY; MORTALITY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; PAIN; PATIENT CARE; QUALITY OF LIFE; RADIATION DERMATITIS; REVIEW; TASTE DISORDER; XEROSTOMIA; HEAD AND NECK TUMOR; METHODOLOGY; NUTRITIONAL ASSESSMENT; STOMATITIS;

COMBINED MODALITY THERAPY; DENTAL CARE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHEDEMA; NUTRITION ASSESSMENT; QUALITY OF LIFE; RADIODERMATITIS; STOMATITIS; XEROSTOMIA;

EID: 38749127200     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Murphy RA, Cmelak A. The role of chemoradiation for oral cavity cancers. Oral Maxilofac Surg Clin N Am. 2006; 18:605-614.
2. Murphy BA, Cmelak A, Bayles S, Dowling E, Billante C. Symptom management: head and neck cancer. In Doyle D, Hanks G, Cherny NI, Calman K, eds. Oxford Textbook of Palliative Medicine. Oxford: Oxford; 2003.
3. Lopez MJ, Robinson P, Madden T, et al. Nutritional support and prognosis in patients with head and neck cancer. J Surg Oncol. 1994; 55:33-36.
4. Mandel DD. The role of saliva in maintaining oral homeostasis. J Am Dent Asoc. 1989;119:298-304.
5. Hall SF, Groome PA, Rothwell, D. The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck. 2000;22:317-322.
6. Chang V. The value of symptoms in prognosis of cancer patients. In: Portenoy RK, Bruera EA, eds. Topics in Palliative Care. Oxford, UK: Oxford; 2000:23-53.
7. van Bokhorst-De van der Schuer MA, von Blomberg-van der Flier BM, Riezebos RK, et al. Differences in immune status between well-nourished and malnourished head and neck cancer patients. Clin Nutr. 1998; 17:107-111.
8. Bentzen SM. Dorr W, Anscher ME, et al. Normal tissue effects: reporting and analysis. Semin Radiat Oncol. 2003; 13:189-202.
9. Perry, A, Shaw M. Evaluation of functional outcomes (speach, swallowing and voice) in patients attending speech pathology after head and neck cancer treatment(s): development of a multi-centre database. J Laryngol Otol. 2000; 114:605-615.
10. Jones, R. Impairment, disability and handicap - old fashioned concepts? J Med Ethics. 2001;27:377-379.
11. Cardol M, Brandsma JW, deGroot IJM, et al. Handicap questionnaires: what do they assess? Disabil Rehabil. 1999;21:97-105.
12. Dodd M. The pathogenesis and characterization of oral mucositis associated with cancer therapy. Oncal Nurs Forum. 2004;315-11.
13. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004;4:277-284.
14. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004; 100(9 suppl): 1995-2025.
15. Worthington HV. Clarkson JE, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database System Rev 2006;2. Art. No.: CD000978. DOI: 10.1002/ 14651858.CD000978.pub2.
16. Mucositis Guidelines; 2006. Available at: http://www.masoc.org/. Accessed October 1, 2007.
17. Marchetta F. Function and appearance following surgery for intraoral cancer. Clin Plastic Surg. 1976;3:471-479.
18. Rosenthal DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol. 2006;24:2636-2643.
19. Epstein JB. Emerton S, Kolbinson DA, et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck. 1999;21:1-11.
20. Murphy BA, Friedman J, Dowling E, Cheatham R, Cmela A. Dietary intake and adapations in head and neck cancer patients treated with chemoradiadon. Proc Am Soc Clin Oncol. 2002;21 Abstract 932.
21. Beecken L, Calman F. A return to "normal eating" after curative treatment for oral cancer. Eur J Cancer B Oral Oncol. 1994:30B:387-392.
22. Brookes GB. Nutritional status-a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg. 1985;93:69-74.
23. van Bokhorst-De van der Schuer MA. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999;86: 519-527.
24. Newman LA, Vieira F, Schwiezet V, et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998; 124:589-592.
25. Hammerlid E, Wirblad B, Snadin C, et al. Malnutrition and food in take in relation to quality of life in head and neck cancer patients. Head Neck. 1998;20:540-548.
26. Colasanto JM, Prasad P, Nash MA, Decker RH, Wilson LD. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park). 2005;19:371-387.
27. Gibson S, Wenig BL. Percutaneous endoscopic gastrostomy in the management of head and neck carcinoma. Laryngoscope. 1992;102:977-981.
28. Schweinfurth JM, Boger GN, Feustel PJ. Preoperative risk assessment for gastrostomy tube placement in head and neck cancer patients. Head Neck. 2001;23:376-382.
29. Lin A, Jabbari S, Worden FP, et al. Metabolic abnormalities associated with weight loss during chemoirradiation of head and neck cancer. Int J Radiat Biol Phys. 2005;63:1413-1418.
30. Daly JM, Hearne B, Dunaj J, et al. Nutritional rehabilitation in patients with advanced head and neck cancer receiving radiation therapy. Am J Surg. 1984;148:514-520.
31. Lee JH, Machtay M, Unger LD, et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:871-875.
32. Harris J, Benedict R. A biometric study of basal metabolism in man. Carnegie Institution publication. 279;1919:40-44.
33. Saunders JR, Brown MS, Hirata RM, Jaques DA. Percutaneous endoscopic gastronomy in patients with head and neck malignancies. Am J Surg. 1991;162:381-383.
34. Bergstrom LR, Larson D, Zinsmeister AR, Sarr MG, Silverstein MD. Utilization and outcomes of surgical gastrostomies and jejunostomies in an era of percutaneous endoscopic gastrostomy: a population-based study. Mayo Clin Proc. 1995;70:829-836.
35. Eisen GM, Baron TH, Dominitz JA, et al. Role of endoscopy in enteral feeding. Gastrointest Endosc. 2002;55:794-797.
36. Silver HJ, Wellman NS, Arnold DJ, Livingstone AS, Byers PM. Older adults on home enteral nutrition: enteral regimen, provider involvement, and health care outcomes. J Parenter Enteral Nutr. 2004;28:92-98.
37. Tisdale M. Metabolic alterations in cachexia and anorexia. Nutrition. 2000;16:1013-1014.
38. Davis MP, Dreicer R, Walsh D, Lagman R. LeGrand SB. Appetite and cancer-associated anorexia: a review. J Clin Oncol. 2004;22:1510-1517.
39. Desport JD, Gory-Delabaere G, Blanc-Vincent MP, et al. Standards, options and recommendations for the use of appetite stimulants in oncology 2000. Br J Cancer. 2003;89(suppl 1):S98-S100.
40. Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R. Supportive use of megestrol acetate in patients with head and neck cancer during-radio(chemo)therapy. Eur J Cancer. 1997;33:75-79.
41. Chen H. Effect of megestrol acetate and propulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy. Radiother Oncol. 1997;43:75-79.
42. Sullivan. M. The expanding role of dental oncology in head and neck surgery. Surg Oncol Clin N Am. 2004;13:37-46.
43. Sonis ST, Fey EG. Oral complications of cancer therapy. Oncology (Williston Park). 2002;16:680-686; discussion 686,691-692, 695.
44. Vissnik A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14:199-212.
45. Bruins HH, Jolly D, Koole R. Preradiation dental extraction decisions in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol. 1999;88: 406-412.
46. Bruins HH, Koole R, Jolly DE. Pretherapy dental decisions in patients with head and neck cancer: a proposed model for dental decision support. Oral Surg Oral Med Oral Pathol 1998;86:256-267.
47. Tong AC, Leung AC, Cheng JC, Sham J. Incidence of complicated healing and osteoradionecrosis following tooth extraction in patients receiving radiotherapy for treatment of nasopharyngeal carcinoma. Aust Dent J. 1999;44:187-194.
48. Hancock PJ, Epstein JB, Sadler GR. Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc. 2003;69:585-590.
49. Rankin KV, Conklin C, Flaitz CM, Haveman CW, Mobley CC, Redding SW. Oral Health in Cancer Therapy. 1999, Austin Texas: Texas Dental Association/Texas Cancer Council.
50. Meraw SJ, Reeve CM. Dental considerations and treatment of the oncology patient receiving radiation therapy. J Am Dent Assoc. 1998;129:201-205.
51. National Cancer Institute. Oral Complications of Chemotherapy and Head/ Neck Radiation. June 2007. Available online: www.cancer.gov.
52. Beltran-Aguilar ED, Goldstein JW, Lockwood SA. Fluoride varnishes: a review of their clinical use, cariostatic mechanism, efficacy and safety. J Am Dent Assoc. 2000;131:589-596.
53. Epstein JB, van der Meij EH, Emerton SM, et al. Compliance with fluoride gel use in irradiated patients. Spec Care Dentist. 1995; 15:218-222.
54. Epstein JB, van der Meij EH, Lunn R, Stevenson-Moore P. Effects of compliance with fluoride gel application on caries and caries risk in patients after radiation therapy for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;82:268-275.
55. Foote RL, Loprinzi CL, Frank AR, et al. Randomized trial of a chlorhexidine mouthwash for the alleviation of radiation induced mucositis. J Clin Oncol. 1994;12:2630-2633.
56. Scully C, Felix DH. Oral medicine - update for the dental practitioner: dry mouth and disorders of salivation. Br Dent J. 2005; 199:423-427.
57. Dodd MJ, Larson PJ, Dibble SL, et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Ferum. 1996; 23:921-927.
58. Cooper JS, Fu K, Marks J, Silverman S. Late effects of radiation therapy in the head and neck region. Int J Radiat Biol Phys. 1995;31:1141-1164.
59. Bjordal, K., Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys. 1994;28:846-856.
60. Harrison LB, Zelefsky MJ, Pfister DG, et al. Derailed quality of life assessment in patients treated with primary radiotherapy for cancer of the base of tongue. Head Neck. 1997;19:169-175.
61. Henson BS, Inglehart MR, Eisbruch A, Ship JA. Preserved salivary output and xerostomia-related quality-of-life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol. 2001;37:84-93.
62. Lin A. Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head and neck cancer: A prospective longitudinal study. Int J Rdiat Oncol Biol Phys. 2003;57:61-70.
63. Murphy BA, Ridner S, Wells N, Dietrich M. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol. 2007;62:251-267.
64. Nelson GM. Biology of taste buds and the clinical problem of taste loss. Anat Rec. 1998;253:70-78.
65. Hamler S, Fault J. Klein B, et al. Mastication and swallowing in patients with postirradiation xerostomia. Int J Radiat Biol Phys. 1997;37:789-796.
66. Logemann J, Smith C, Paulowski B, et al. Effects of xerostomia on perception and performance of swallow function. Head Neck. 2001;23:317-321
67. Backstrom I, Funegard U, Andersson I, Franzen L, Johansson. Dietary intake in head and neck irradiated patients with permanent dry mouth symptoms. Eur J Cancer B Oral Oncol. 1995;31B:253-257.
68. Roh JL, Kim AY, Cho MJ, Xerostomia following radiotherapy of the head and neck aflects vocal function. J Clin Oncol. 2005;23:3016-3023.
69. Rhodus NL, Moller K, Colby S, Bereuter J, Articulatory speech performance in patients with salivary gland dysfunction: a pilot study. Quintessence Int. 1995;26:805-810.
70. Haddad P, Karimi M. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiother Oncol. 2002;64:29-32.
71. Reike JW, Hafermann MD, Johnson JT, et al. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiat Biol Phys. 1995;31:661-669.
72. Fisher J, Scott C, Scarantino CW, et al. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head and neck cancer - RTOG 97-09. Int J Radiat Biol Phys. 2003;56:832-836.
73. Gornitsky M, Shenouda G. Sultanem K, et al. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Oral Surg Oral Med Oral Pathol. 2004;98:45-52.
74. Fife RS, Chase WF, Dore RK, et al. Cevimeline for the treatment of xerostomia in patients with Sjorgren syndrome: a randomized trial. Arch Intern Med. 2002;162:1293-1300.
75. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000;18: 3339-3345.
76. Seikaly H, Jha N, Harris JR, et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol. 2004;130:956-961.
77. Rosenthal DI. Chambers MS, Weber RS, Eisbruch A. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid sparing. Semin Oncol. 2004;31(6 suppl 18):25-28.
78. Sitton E. Early and late radiation-induced skin alterations part 1: Mechanism of skin changes. Oncol Nurs Forum. 1992;19:801.
79. Blackmar A. Radiation-induced skin alterations. Medsurg Nurs. 1997;6: 172-175.
80. Rubin P, Cassarett GW. Clinical Radiation Pathology. 1968, Philadelphia: Saunders.
81. Stohl R. The nursing role in radiation oncology: symptom management of acute and chronic reactions. Oncol Nurs Forum. 1988;15:429-434.
82. Rockson S. Lymphedema. Am J Med. 2001;110:288-295.
83. Micke O, Bruns F, Mucke R. et al. Selenium in the treatment of radiation-associated secondary lymphodema. Int J Radiat Oncol Biol Phys. 2003;56:40-49.
84. Cheville A. Lymphedema and palliative care. National Lymphedema Network. Lymphlink. 2002;14:1-4.
85. Weissleder H, Schuchhardt C. Lymphedema Diagnosis and Therapy. 2001: Koln, Germany: Viavital Verlag GmbH.
86. Hiss SG, Postma GN. Fiberoptic endoscopic evaluation of swallowing. Laryngoscope. 2003;113:386-1383.
87. Williams WH, Witte CL, Witte MH, et al. Radionuclide lymphangioscinigraphy in the evaluation of peripheral lymphedema. Clin Nucl Med. 2000;25: 451-464.
88. Szuba A, Strauss W, Sirsikar SP, et al. Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity. Nucl Med Commun. 2002;23:1171-1175.
89. de Wit R, van Dam F, Loonstra S, et al. The Amsterdam Pain Management Index compared to eight frequently used outcome measures to evaluate the adequacy of pain treatment in cancer patients with chronic pain. Pain. 2001;91: 339-349.
90. Olszewski W. Inflammatory changes of skin in lymphedema of extremities and efficacy of benzashine penicillin administration. National Lymphedema Network LymphLink. 1996. 8: p. 1-2.
91. Hess M. Taste: the neglected nutritional facton. J Am Diet Assoc. 1997;97: S205-S207.
92. Smith BK, Barker K, Schork A, Kluger M. Development of altered taste preferences in tumor-bearing rats. Appetite. 1994;23:219-230.
93. Williams LR, Cohen MH. Altered taste thresholds in lung cancer. Am J Clin Nutr. 1978;31:122-125.
94. Carson JS, Gormican A. Taste acuity and food attitudes of selected patients with cancer. J Am Diet Assoc. 1977;70:361-365.
95. Mossman KL, Chencharirk JD, Scherr AC, et al. Radiation-induced changes in gustatory function. Int J Radiat Biol Phys. 1979;5:521-528.
96. DeWys WD, Walters K. Abnormalities of taste sensation in cancer patients. Cancer. 1975;36:1888-1896.
97. Halyard MY, Jatio A., Sloan JA, et al. Does zinc sulfate prevent radiation-induced taste alterations ("dysgeusia") in head and neck cancer patients? A North Central Cancer Treatment Group (NCCTG) placebo-controlled trial (N01C4). Proceedings Multidisciplinary Head and Neck Cancer Symposium. 2007:111: Abstract 32.
98. Chaplin JM, Morton RP. A prospective, longitudinal study of pain in head and neck cancer patients. Head Neck. 1999;21;531-537.
99. Isitt J, Murphy BA, Beaumont JL, et al. Oral mucositis related morbidity and resburce utilization is a prospective study of head and neck cancer patients. Proc Am Soc Clin Oncol. 2006;24:289, Abstract 5539.
100. Epstein JB, Beaumont JL, Gwene CK, et al. Longitudinal valuation of the oral mucositis weekly questionnaire - head and neck cancer, a patient-reported outcome questionnaire. Cancer. 2007; 109:1914-1922.
101. Keefe DM, Garden A, Barasch A, et al. Oral mucositis is associated with increased resource use among patients receiving treatment for cancers of the head and neck. Proc Am Soc Clin Oncol. 2007;25. Abstract 6070.
102. Murphy BA, Chen A, Harari P, et al. Longitudinal oncology registry of head and neck carcinoma: (LORHAN), a new national cancer registry. Proceedings Multidisciplinary Head and Neck Cancer Symposium. 2007. Presentation 7.
103. Smit M, Balm AJ, Hilgers FJ, Tan IB. Pain as sign of recurrent disease in head and neck squamous cell carcinoma. Head Neck. 2001;23:372-375.
104. Wisawatapnimit P, Dwyer K, Murphy B. Life experience of head and neck cancer patients and their caregivers after treatment. Paper presented at: Southern Nursing Research Society Meeting, 2006; Memphis, Tenn.